HGF and B-cell chronic lymphocytic leukemia: Specifically, HGF activates the AKT, ERK, and STAT3 pathways (Figures 2A, B; Supplementary Figure S1A, B), which are crucial for CLL cell survival, proliferation, and resistance to apoptosis and drug treatment (Xiao et al., 2001).